Treatment Category Profile

Treatment Name:	Gemzar	Known as: Also Known As:	Gemcitabine
Treatment Type:	Chemotherapy	Status:	FDA Approved Tx
Gemzar (Trade name) is a prescription drug that is approved by the FDA for the treatment of non-small cell lung cancer and pancreas cancer. It is a chemotherapy agent that has been combined with other agents in RCC clinical trials.

   Articles related to this Treatment

1 Gemcitabine/5-Fluorouracil Does Not Appear To Be More Effective In One Metastatic Renal Cancer Subgroup Over Another DG News Oct 1, 2003 2 Gemcitabine with Immunotherapy Effective for Metastatic Renal Cell Cancer in Small Study cancerpage.com Sep 18, 2002 3 Future directions for gemcitabine in the treatment of genitourinary cancer. PubMed Feb 1, 2002 4 A Phase II Trial of Weekly Intravenous Gemcitabine (G) with Prolonged Continuous Infusion 5-Fluorouracil (F) and Oral Thalidomide (T) in Patients with Metastatic Renal Cell Cancer (mRCC). ASCO Online Jan 1, 2001 5 A Phase II Trial of Weekly Intravenous Gemcitabine (G) and Cisplatin (C) with Prolonged Continuous Infusion 5-Fluorouracil (F) in Patients (Pts) with Metastatic Renal Cell Carcinoma (RCC). ASCO Online Jan 1, 2001